. Intravasation and Other Steps in the Metastatic Cascade second round of invasion, extravasation, whereby neoExamined in the Report by Kim et al. (1998) plastic cells exit from the vessel lumen into the sur- pel has disposed of the primary tumor. At a more basic Folkman, 1996; Zetter, 1998) , and are seeing the suc-A clever trick used by Kim et al. (1998) for the detection of very small numbers of intravasated tumor cells in the cessful dissection of the last steps, lodgement, extravasation, and secondary growth (Chambers and Matrisian, organs of assay was the quantitation of Alu sequences, present in high abundance in the DNA of the explanted 1997), but until the appearance of a paper from Kim et al. (1998 [this issue of Cell]), we knew essentially nothing human tumor cells but absent from the host chicken cells. The Alu sequences, unique to human and higher about the important step of tumor cell intravasation. In order to accomplish intravasation, the tumor cell must primate DNA, are repetitive sequences approximately 300 bp long and flanked at each end by highly conserved traverse the subendothelial basal lamina and move across or eliminate the single-cell layer of endothelial 25 bp and 16 bp regions. Sense and antisense primers designed from these regions enabled the conserved cells that separates tumor tissue from the blood. One of the interesting findings of this report is the demonstraends to be used for PCR amplification of human Alu DNA in a background of chicken DNA. PCR amplification tion of essential roles for matrix metalloproteases (MMPs) and for the urokinase plasminogen activator receptor yielded a 220 bp radiolabeled band whose intensity was proportional to the amount of human DNA present with (uPAR), and, by implication, for urokinase plasminogen activator (uPA).
a large excess of chicken DNA. Chicken DNA alone failed to yield a PCR product, and as little DNA as from 50 Our understanding of the molecular and cellular mechanisms of metastasis has depended on the exploihuman cells added to the chick tissue yielded a detectable 220 bp signal. The detection trap for intravasation tation of model systems that isolate one or another of the individual steps of this complicated, multistep prowas set. Kim et al. (1998) assayed intravasation by the appearcess. In this context, the use by Kim et al. (1998) of the chick chorioallantois for the characterization of tumor ance of human tumor cells in tissues distant from the site of inoculation and connected to that location only intravasation was inspired. This is an in vivo model that is facile, inexpensive, experimentally manipulable, and by the vascular and lymphatic systems. The logic was that tumor cells found at these distant sites must have that readily accepts and supports xenogenic transplants. It is just such a xenogenic difference between reached them by vascular or lymphatic transport, and for transport to have occurred, the tumor cells had to host (chicken) and tumor (human) that Kim et al. (1998) exploited for the detection and quantitation of the intrahave successfully intravasated into the blood or lymph. The path taken by tumor cells that have intravasated vasated tumor cells (see below). In the chorioallantois grafting system, the chorioallantois is exposed by cutinto chorioallantoic capillaries is to the chorioallantoic veins, then to the allantoic vein, which discharges into ting a window in the egg shell and tumor cells are then explanted onto a suitably traumatized chorionic epithethe posterior chamber of the heart. The cardiac blood, with its cargo of intravasated tumor cells, then is distriblium (Armstrong et al., 1982) . The explanted cells invade across the damaged epithelium and into the mesenchyuted to the body, with a major portion flowing directly via the allantoic arteries back to the chorioallantois. It mal connective tissue beneath, where they find a dense bed of blood vessels that is the target for intravasation.
is vascular-borne tumor cells delivered by this pathway and captured by the capillary bed of regions of the choThe chorioallantois is an extraembryonic organ formed at day 4-5 of development (E4-E5) by the fusion of the rioallantois distant from the graft that were assayed by Kim et al. (1998) (Figure 1) . A second site for metastatic allantois and the chorion. It has a bilayered chorionic epithelium positioned immediately beneath the egg arrest was found to be the embryonic liver. When highly malignant, human epidermoid carcinoma shell, a mesenchymal bed composed of mesoderm from chorion and allantois, and an inner allantoic epithelium cells (HEp-3) were inoculated onto the patch of chorioallantois exposed by the shell window (designated the that encloses the allantoic cavity. During the next 7-8 days of development, the chorioallantois expands be-"upper half chorioallantois"), a significant level of human 220 bp PCR product was detected 30-50 hr later in neath the egg shell, eventually to envelop the entire embryo. Between E7 and the stage of pipping at E20, the chorioallantois directly opposite the inoculation site (designated the "lower half chorioallantois"). Kim et al. the chorioallantois serves as the respiratory organ of the embryo. The chorioallantoic vasculature is contrib-(1998) demonstrated that the PCR signal measures DNA from live tumor cells and not DNA from cellular debris, uted by the allantoic mesoderm and vascularizes the mesenchyme and, in addition, establishes a dense capilthat its appearance is dose dependent on the tumor cell inoculum, and that the tumor cells are not entering the lary plexus by E10-E12 that intrudes directly into the chorionic epithelium. The endothelium shows rapid cell vasculature passively or incidently at inoculation but, instead, must complete active intravasation into the host proliferation from E4 to E11, after which the rate of proliferation experiences a rapid decline. It is at this stage embryo vasculature. The intravasation process, thus, is active, progressive, and is initiated at a defined time that the chorioallantois completes its growth and the ectodermal capillary plexus becomes established. The period (30-50 hr postinoculation). Importantly, the intravasation process appears to be specific and selective. In capillaries during the growth stage show a thin and incomplete basal lamina and focal contact junctions beaddition to HEp-3, MDA-231, a highly malignant breast carcinoma cell line, intravasates, while MCF-7, a nonagtween endothelial cells that prevent transendothelial passage of molecules larger than ‫02ف‬ kDa. Since large gressive breast tumor cell line does not. PC-3, a highly malignant prostate tumor cell enters the chorioallantoic areas of the capillary endothelium are devoid of a basal lamina, it is presumed that the interstitial matrix and vasculature, while LNCaP, a weakly malignant prostate tumor cell, does not. Other malignant and nonmalignant the adhesive junctions of the endothelium represent the major barriers to intravasation of tumor cells.
pairs of cell lines yielded similar differential results. At the stages of initial detection of tumor cells in the ventral Of the major MMPs, MMP-9 has in the past suffered from some neglect, existing in the shadow of MMP-2, half chorioallantois, the inoculum had yet to form itself into a definitive tumor and appears not yet to have acits close structural and functional homolog. An involvement of MMP-9 in a variety of normal and pathological tively elicited a vascular supply, indicating that differences in angiogenesis of the different cell lines cannot conditions has recently begun to emerge, however. Werb and colleagues (Vu et al., 1998) demonstrated that underlie the observed differences in intravasation. It appears that the malignant cells utilized the preexisting the MMP-9 gene knockout mouse exhibits a transient enlargement in the osteogenic growth plate that correchorioallantoic vasculature for intravasation. Furthermore, since cells of all cell lines delivered to the blood lates with reduced angiogenesis of hypertrophic cartilage. This defect can be corrected by bone marrow by direct intravascular injection arrested in the capillary bed of the chorioallantois with equal efficiency, differtransplants from wild-type mice. Muschel and coworkers (Bernard et al., 1994; Hua and Muschel, 1996) ences in arrest could not account for these observations. Recent reports indicate that extravasation of cells showed both by transfection of MMP-9 cDNA and by transfection with specific antisense-RNA-ribozyme conarrested in the chorioallantoic vasculature shows no selectivity for tumor cells, with nonneoplastic cells exstructs that enhanced expression of MMP-9 in nonmetastatic cells activated a metastatic phenotype, and selectravasating as efficiently as tumor cells (Koop et al., 1996) . Thus, Kim et al. (1998) appear to have been suctive loss of MMP-9 mRNA results in cells that retain tumorigenicity but are no longer metastatic. Consistent cessful in isolating intravasation as the rate-limiting and selective step in their assay.
with the link by Kim et al. (1998) of intravasation to both MMP-9 and the uPA/uPAR system, recent studies by With intravasation defined and quantifiable in the model, Kim et al. (1998) examined the enzymic require- Mazzieri et al. (1997) and Ramos-De Simone et al. (1998) have shown that activation of pro-MMP-9 is accomments of the process. An involvement of uPA and its cell surface receptor, uPAR had already been docuplished by a uPA/plasmin/MMP proteolytic cascade. The requirement both for MMP-9 and for uPA for intravamented for various facets of invasion and metastasis (Ossowski, 1988; Kook et al., 1994) , so for the present sation may reflect just this sort of complex proteolytic activation cycle. The principal targets of the MMPs are study, their role in intravasation was examined directly. Modified sublines of HEp-3 cells, in which surface uPAR proteins of the extracellular matrix, suggesting an involvement in remodeling the stromal matrix of the chowas reduced by 50%-70% through transfection of a vector expressing antisense RNA for uPAR, exhibited rioallantois to enable the grafted tumor cells to contact the endothelium. The uPA/plasmin system is more broadly dramatically reduced intravasation compared to parental HEp-3 or cells transfected with the vector alone. This targeted and might play a dual role in intravasation: the activation of MMP zymogens and the facilitation of implicates the uPA/uPAR cell surface proteolytic system in the intravasation process. MMPs were also examined invasion across the endothelium itself and/or promotion of the release of tumor cells into the blood after intravausing substrate zymography to examine representative MMPs of all eight of the intravasating and nonintravasatsation has been accomplished. A key to the success of the pioneering investigation ing cell lines. MMP-1 (interstitial collagenase), MMP-2 (gelatinase A), and MMP-9 (gelatinase B) were produced by Kim et al. (1998) of the intravasation step of tumor metastasis was the choice of the chicken chorioallantois to varying levels by all of the cell lines. MMP-9 was the only one of the three MMPs that was consistently as the host tissue. The chorioallanotis has long been a favored system for the study of tumor angiogenesis and present in the intravasating cell types and absent or barely detectable in the nonintravasating cells. Further, as a system for investigating metastasis of human tumor cells. In addition to its several key advantages for the the general MMP inhibitor, Marimastat, produced a 90% reduction of intravasation, indicating that MMPs are present study, it has the additional advantage of favorable optical clarity for intravital microscopy. This method necessary for this process. The absence of any toxic effect by Marimastat and the documented specificity of allows the continuous microscopic observation of cells within the vasculature of the living chorioallantois and this class of inhibitors strongly implicates MMP proteolytic function in the process of intravasation. The purhas proven informative for the study of extravasation of injected tumor cells arrested in the microvasculature ported involvement specifically of MMP-9 in intravasation, however, is not as compelling, because it is based (Koop et al., 1996) . In the present context, it will be on circumstantial evidence (i.e., tumor cells that intravainformative to compare the detailed behavior of grafted sate secrete MMP-9, while those that do not fail to excells of the different intravasating and nonintravasating press significant quantities of the enzyme). Many memcell lines and the behavior of control and Marimistatbers of the MMP family are not detectable by gelatin treated HEp-3 cells during the process of intravasation zymography, and one or another of these undetected itself by direct microscopic study of the living tissues. MMPs might be an active agent in intravasation and
Of the different systems available for the study of metaswould, of course, be inactivated by Marimistat. More tasis, arguably the chick chorioallanotis is the most verdirect studies of a role for MMP-9 could include activatsatile and, for the study of intravasation, is the premier ing intravasation-incompetent tumor cell lines by transchoice. fection with cDNA for MMP-9, and eliminating MMP-9 from intravasation-competent cell lines with antisense antibodies.
